Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DEXTENZA for the Treatment of Pain and Inflammation Following Surgical Trabeculectomy and Ahmed Valve Procedures

NCT05116345 is registered in ClinicalTrials.gov with Brian Jerkins, MD as lead sponsor.

NCT NCT05116345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05116345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DEXTENZA for the Treatment of Pain and Inflammation Following Surgical Trabeculectomy and Ahmed Valve Procedures
Lead sponsor
Brian Jerkins, MD
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2021
Completion date
November 30, 2023
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma following surgery